Status:
UNKNOWN
A Prospective Study Comparing the Success Rate of Injection of (DefluxR) Versus (VantrisR) for VUR in Children
Lead Sponsor:
Rabin Medical Center
Conditions:
Vesico-Ureteral Reflux
Eligibility:
All Genders
1-18 years
Phase:
PHASE4
Brief Summary
Vesicoureteral reflux (VUR) is the most common urologic diagnosis in neonates estimated at 1% of newborns, and 30-45% of the children who present with urinary tract infection (1). Optional treatments...
Detailed Description
Vesicoureteral reflux (VUR) is the most common urologic diagnosis in neonates estimated at 1% of newborns, and 30-45% of the children who present with urinary tract infection (1). Optional treatments...
Eligibility Criteria
Inclusion
- Bilateral VUR of the same grade
Exclusion
- Inability to apply the same technique on both ureteral orifices
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02271035
Start Date
October 1 2014
End Date
December 1 2015
Last Update
October 22 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Schneider Medical Center of Israel
Petah Tikva, Israel, Israel